Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity
- 31 August 2006
- journal article
- Published by Elsevier BV in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 75 (2), 81-90
- https://doi.org/10.1016/j.plefa.2006.06.004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitroJournal of Endocrinology, 2001
- Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariaeJournal of Endocrinology, 1998
- Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrowBone, 1997
- Systemic administration of an anabolic dose of prostaglandin E2 induces early-response genes in rat bonesBone, 1997
- Increased bone growth by local prostaglandin E2 in ratsCalcified Tissue International, 1993
- Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized ratsBone, 1990
- The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2Bone, 1987
- The effects of prostaglandin E2 in rapidly growing rats: Depressed longitudinal and radial growth and increased metaphyseal hard tissue massBone, 1985
- The effects of prostaglandin E2 in growing rats: Increased metaphyseal hard tissue and cortico-endosteal bone formationCalcified Tissue International, 1985
- Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease.Radiology, 1982